Cobalt chloride-induced estrogen receptor α down-regulation involves hypoxia-inducible factor-1α in MCF-7 human breast cancer cells

Molecular Endocrinology

Volumn 19, Issue 5, 2005, Pages 1191-1199

  Cho, Jungyoon ^a   Kim, Dukkyung ^b   Lee, SeungKi ^c   Lee, YoungJoo ^a  

^a Sejong University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COBALT CHLORIDE; ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEASOME; VIRUS PROTEIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ANOXIA; ANTIMUTAGENIC AGENTS; BREAST NEOPLASMS; COBALT; DNA-BINDING PROTEINS; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HERPES SIMPLEX VIRUS PROTEIN VMW65; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS;

HERPES; MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 17844400028     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0162     Document Type: Article

References (43)

1. Beato M, Klug J 2000 Steroid hormone receptors: an update. Hum Reprod Update 6:225-236
2. Reid G, Denger S, Kos M, Gannon F 2002 Human estrogen receptor-α: regulation by synthesis, modification and degradation. Cell Mol Life Sci 59:821-831
3. McDonnell DP, Norris JD 2002 Connections and regulation of the human estrogen receptor. Science 296:1642-1644
4. Shao W, Brown M 2004 Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res 6:39-52
5. Alarid ET, Bakopoulos N, Solodin N 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534
6. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR 1987 Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1:68-74
7. Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke LA 2003 Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22:7316-7339
8. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW 1999 Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858-1862
9. Nawaz Z, O'Malley BW 2004 Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18:493-499
10. Alarid ET, Preisler-Mashek MT, Solodin NM 2003 Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-α protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144:3469-347
11. Stoner M, Saville B, Wormke M, Dean D, Burghardt R, Safe S 2002 Hypoxia induces proteasome-dependent degradation of estrogen receptor α in ZR-75 breast cancer cells. Mol Endocrinol 16:2231-2242
12. Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R, Safe S 2003 The aryl hydrocarbon receptor mediates degradation of estrogen receptor a through activation of proteasomes. Mol Cell Biol 23:1843-1855
13. Cassoni P, Catalano MG, Sapino A, Marrocco T, Fazzari A, Bussolati G, Fortunati N 2002 Oxytocin modulates estrogen receptor α expression and function in MCF7 human breast cancer cells. Int J Oncol 21:375-378
14. Brahimi-Horn C, Berra E, Pouyssegur J 2001 Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol 11:S32-S36
15. Semenza GL, Agani F, Iyer N, Jiang BH, Leung S, Wiener C, Yu A 1998 Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology. Chest 114:40S-45S
16. Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W, Stern D 1998 Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95:8298-8303
17. Mazure NM, Chauvet C, Bois-Joyeux B, Bernard MA, Nacer-Cherif H, Danan JL 2002 Repression of α-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res 62:1158-1165
18. Kurebayashi J, Otsuki T, Moriya T, Sonoo H 2001 Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer 92:1093-1101
19. El Khissiin A, Leclercq G 1999 Implication of proteasome in estrogen receptor degradation. FEBS Lett 448:160-166
20. Marsaud V, Gougelet A, Maillard S, Renoir JM 2003 Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor α (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Mol Endocrinol 17:2013-2027
21. Brunnberg S, Pettersson K, Rydin E, Matthews J, Hanberg A, Pongratz I 2003 The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc Natl Acad Sci USA 100:6517-6522
22. Vincent KA, Shyu KG, Luo Y, Magner M, Tio RA, Jiang C, Goldberg MA, Akita GY, Gregory RJ, Isner JM 2000 Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor. Circulation 102:2255-2261
23. Belanger AJ, Lu H, Date T, Liu LX, Vincent KA, Akita GY, Cheng SH, Gregory RJ, Jiang C 2002 Hypoxia up-regulates expression of peroxisome proliferator-activated receptor γ angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1α. J Mol Cell Cardiol 34:765-774
24. Fan M, Bigsby RM, Nephew KP 2003 The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the antiproliferative activity of ICI 182,780 in ER α-positive breast cancer cells. Mol Endocrinol 17:356-365
25. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D 2001 Hyperactivation of MAPK induces loss of ER α expression in breast cancer cells. Mol Endocrinol 15:1344-1359
26. Holloway JN, Murthy S, El-Ashry D 2004 A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-α down-regulation in breast cancer cells: the role of nuclear factor-κB. Mol Endocrinol 18:1396-1410
27. Hur E, Chang KY, Lee E, Lee SK, Park H 2001 Mitogen-activated protein kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1α. Mol Pharmacol 59:1216-1224
28. Lobenhofer EK, Huper G, Iglehart JD, Marks JR 2000 Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ 11:99-110
29. Xirodimas DP, Seville MK, Bourdon JC, Hay RT, Lane DP 2004 Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118:83-97
30. Chen D, Li M, Luo J, Gu W 2003 Direct interactions between HIF-1 α and Mdm2 modulate p53 function. J Biol Chem 278:13595-13598
31. Hansson LO, Friedler A, Freund S, Rudiger S, Fersht AR 2002 Two sequence motifs from HIF-1α bind to the DNA-binding site of p53. Proc Natl Acad Sci USA 99:10305-10309
32. Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y, Saji S, Hayashi S 2001 MDM2 enhances the function of estrogen receptor α in human breast cancer cells. Biochem Biophys Res Commun 281:259-265
33. Minet E, Mottet D, Michel G, Roland I, Raes M, Remade J, Michiels C 1999 Hypoxia-induced activation of HIF-1: role of HIF-1α-Hsp90 interaction. FEBS Lett 460:251-256
34. Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, Murakami S, Kim CW, Kim KW 2004 Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1α. FASEB J 18:382-384
35. Catherino WH, Wolf DM, Jordan VC 1995 A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog. Mol Endocrinol 9:1053-1063
36. Cicatiello L, Addeo R, Altucci L, Belsito Petrizzi V, Boccia V, Cancemi M, Germano D, Pacilio C, Salzano S, Bresciani F, Weisz A. Cicatiello L, Addeo R, Altucci L, Belsito Petrizzi V, Boccia V, Cancemi M, Germano D, Pacilio C, Salzano S, Bresciani F, Weisz A 2000 The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion. Mol Cell Endocrinol 165:199-209
37. Kurebayashi J 2003 Endocrine-resistant breast cancer: underlying mechanisms and strategies for overcoming resistance. Breast Cancer 10:112-119
38. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN 2000 Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 97:10972-10977
39. Coradini D, Pellizzaro C, Speranza A, Daidone MG 2004 Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens. Cell Mol Life Sci 61:76-82
40. Martini PG, Delage-Mourroux R, Kraichely DM, Katzenellenbogen BS 2000 Prothymosin α selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol Cell Biol 20:6224-6232
41. Jang HS, Kim HJ, Kim JM, Lee YS, Kim KL, Kim JA, Lee JY, Sun W, Choi JH, Jeon ES, Byun J, Kim DK 2004 A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle. Mol Ther 9:464-474
42. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ, Kim KW 2002 Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111:709-720
43. Lee YJ, Gorski J 1996 Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc Natl Acad Sci USA 93:15180-15184